October 2026
Adasuve
loxapine
Powder (inhalation) · NDA 022549
Last listed protection ends
October 23, 2026
The FDA lists 1 patent for Adasuve, and this is the day the last one ends. It is not the date a generic goes on sale.
Patents and exclusivities
- Patent 8,387,612Claims the drug product